Detalles de la búsqueda
1.
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma.
Future Oncol
; 20(4): 179-190, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37671748
2.
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.
Future Oncol
; : 1-16, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647011
3.
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors.
Oncologist
; 21(12): 1483-1491, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27449521
4.
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.
Target Oncol
; 14(5): 505-525, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535338
5.
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 275, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651359
6.
Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.
Cancer Treat Rev
; 66: 104-113, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730461
7.
Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy.
Clin Colorectal Cancer
; 16(2): e29-e37, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081962
8.
Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
Mol Pharmacol
; 71(6): 1463-74, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17325130
9.
The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions.
Mol Pharmacol
; 67(4): 983-91, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15625277
Resultados
1 -
9
de 9
1
Próxima >
>>